Fed's Stress Test Overhaul Reduces Capital Uncertainty for BAC, but Does Not Shift Near-Term Earnings Thesis

What happened

The Federal Reserve announced a revamp of its bank stress tests aimed at reducing capital requirement swings and improving planning visibility for large U.S. banks including Bank of America. The change responds to industry criticism that stress capital buffers have been volatile and hard to predict, creating uncertainty for capital planning. For BAC, which already holds a CET1 ratio of 11.2% against a 10.0% minimum, a more predictable stress capital buffer could lower regulatory capital uncertainty and potentially support steady buyback planning. However, the overhaul does not address BAC's more immediate issues: management's guide for a 10% decline in 3Q26 investment-banking fees, the need for net interest income to hold near $16 billion, and the stock's rich valuation at 1.96x tangible book. While positive for long-term capital efficiency, the news does not change the near-term earnings or valuation equation that underpins the current WAIT rating.

Implication

Investors should treat this regulatory change as incremental rather than thesis-changing. Lower capital requirement volatility could allow BAC to sustain share repurchases with less risk of regulatory pause, which is supportive for per-share value over time. However, the current price already reflects BAC's strong capital position and buyback capacity, as evidenced by the $6 billion of buybacks in 2Q26. The more important catalysts remain October's 3Q26 earnings, which must confirm NII stability and fee resilience, and the relative performance against JPMorgan in investment banking. Until those checkpoints clear, the stress-test news is insufficient to justify paying 13.1x earnings and 1.96x tangible book. Therefore, the WAIT rating and $53 attractive entry remain justified, with no change to the base-case value of $59.

Thesis delta

The prior thesis viewed BAC's $57.71 price as reflecting durable NII and temporary fee weakness, with capital strength as downside protection. The Fed's stress test overhaul adds a mild positive by potentially reducing the variability of BAC's stress capital buffer, which could smooth capital return capacity. However, this does not address the thesis's central concerns about near-term IB fee softness, NII durability, and BAC-specific competitive momentum, leaving the WAIT rating and valuation conclusions unchanged.